Mesoblast Reports Operational and Financial Highlights for
NEW YORK, May 25, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...
Source: globenewswire.com
Product Potency News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Product Potency. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Product Potency Today - Breaking & Trending Today
Mesoblast Reports Operational and Financial Highlights for Quarter Ended March 31, 2023
26.05.2023 - NEW YORK, May 25, 2023 (GLOBE NEWSWIRE) - Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reported operational highlights and financial results for the period ended March ...
Source: wallstreet-online.de
Remestemcel-L Clinical and Potency Studies Presented at Premier Meeting of Transplantation Research and Therapy
17.02.2023 - NEW YORK, Feb. 16, 2023 (GLOBE NEWSWIRE) - Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that two studies on the remestemcel-L development program for the ... Seite 1
Source: wallstreet-online.de
Remestemcel-L Clinical and Potency Studies Presented at
NEW YORK, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...
Source: globenewswire.com